Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Mexiletine on Cortical Hyperexcitability in Sporadic Amyotrophic Lateral Sclerosis (SALS)

NCT02781454 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT02781454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02781454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Mexiletine on Cortical Hyperexcitability in Sporadic Amyotrophic Lateral Sclerosis (SALS)
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2016
Completion date
September 30, 2018
Enrollment
20 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

sporadic amyotrophic lateral sclerosis